157 related articles for article (PubMed ID: 28711407)
1. Severe neuroimaging anomalies are usually associated with random X inactivation in leucocytes circulating DNA in X-linked dominant Incontinentia Pigmenti.
Dangouloff-Ros V; Hadj-Rabia S; Oliveira Santos J; Bal E; Desguerre I; Kossorotoff M; An I; Smahi A; Bodemer C; Munnich A; Steffann J; Boddaert N
Mol Genet Metab; 2017 Nov; 122(3):140-144. PubMed ID: 28711407
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of low-level mosaicism of the IKBKG mutation using the X Chromosome Inactivation pattern in Incontinentia Pigmenti.
Kawai M; Kato T; Tsutsumi M; Shinkai Y; Inagaki H; Kurahashi H
Mol Genet Genomic Med; 2020 Dec; 8(12):e1531. PubMed ID: 33085210
[TBL] [Abstract][Full Text] [Related]
3. Incontinentia pigmenti (Bloch-Sulzberger syndrome).
Narayanan MJ; Rangasamy S; Narayanan V
Handb Clin Neurol; 2015; 132():271-80. PubMed ID: 26564087
[TBL] [Abstract][Full Text] [Related]
4. High-dose glucocorticoid therapy in the management of seizures in neonatal incontinentia pigmenti: a case report.
Wolf DS; Golden WC; Hoover-Fong J; Applegate C; Cohen BA; Germain-Lee EL; Goldberg MF; Crawford TO; Gauda EB
J Child Neurol; 2015 Jan; 30(1):100-6. PubMed ID: 24682289
[TBL] [Abstract][Full Text] [Related]
5. The common NF-κB essential modulator (NEMO) gene rearrangement in Korean patients with incontinentia pigmenti.
Song MJ; Chae JH; Park EA; Ki CS
J Korean Med Sci; 2010 Oct; 25(10):1513-7. PubMed ID: 20890435
[TBL] [Abstract][Full Text] [Related]
6. Incontinentia Pigmenti: A Summary Review of This Rare Ectodermal Dysplasia With Neurologic Manifestations, Including Treatment Protocols.
Greene-Roethke C
J Pediatr Health Care; 2017; 31(6):e45-e52. PubMed ID: 28870493
[TBL] [Abstract][Full Text] [Related]
7. Incontinentia pigmenti in boys: Causes and consequences.
Chambelland A; Aubert H; Bourrat E; Morice-Picard F; Puzenat E; Lacour JP; Chiaverini C;
Ann Dermatol Venereol; 2020 Mar; 147(3):188-193. PubMed ID: 31982174
[TBL] [Abstract][Full Text] [Related]
8. A Novel Frameshift Mutation of the IKBKG Gene Causing Typical Incontinentia Pigmenti.
Minić S; Trpinac D; Obradović M
Srp Arh Celok Lek; 2015; 143(11-12):752-4. PubMed ID: 26946775
[TBL] [Abstract][Full Text] [Related]
9. Incontinentia pigmenti, an x-linked dominant disorder, in a 2-year-old boy with Klinefelter syndrome.
Williams A; Chandrashekar L; Srivastava VM; Thomas M; Horo S; George R
Indian J Pathol Microbiol; 2017; 60(3):424-426. PubMed ID: 28937389
[TBL] [Abstract][Full Text] [Related]
10. A novel IKBKG mutation in a patient with incontinentia pigmenti and features of hepatic ciliopathy.
Danescu S; Has C; Baican C; Müller T; Baican A
Australas J Dermatol; 2018 Nov; 59(4):e262-e265. PubMed ID: 29520766
[TBL] [Abstract][Full Text] [Related]
11. Clinical profile of comorbidity of rare diseases in a Tunisian patient: a case report associating incontinentia pigmenti and Noonan syndrome.
Ghedira N; Lagarde A; Ben Ameur K; Elouej S; Sakka R; Kerkeni E; Chioukh FZ; Olschwang S; Desvignes JP; Abdelhak S; Delague V; Lévy N; Monastiri K; De Sandre-Giovannoli A
BMC Pediatr; 2018 Aug; 18(1):286. PubMed ID: 30157809
[TBL] [Abstract][Full Text] [Related]
12. Incontinentia pigmenti diagnostic criteria update.
Minić S; Trpinac D; Obradović M
Clin Genet; 2014 Jun; 85(6):536-42. PubMed ID: 23802866
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of neurological manifestations in a boy with incontinentia pigmenti.
Margari L; Lamanna AL; Buttiglione M; Craig F; Petruzzelli MG; Terenzio V
Eur J Pediatr; 2013 Sep; 172(9):1259-62. PubMed ID: 23652938
[TBL] [Abstract][Full Text] [Related]
14. Incontinentia pigmenti in an XY boy: case report and review of the literature.
Mullan E; Barbarian M; Trakadis Y; Moroz B
J Cutan Med Surg; 2014; 18(2):119-22. PubMed ID: 24636437
[TBL] [Abstract][Full Text] [Related]
15. Late-onset cerebral arteriopathy in a patient with incontinentia pigmenti.
Kanai S; Okanishi T; Kawai M; Yoshino G; Tsubouchi Y; Nishimura Y; Sakuma H; Kurahashi H; Maegaki Y
Brain Dev; 2021 Apr; 43(4):580-584. PubMed ID: 33419638
[TBL] [Abstract][Full Text] [Related]
16. Improved molecular diagnosis of the common recurrent intragenic deletion mutation in IKBKG in a Filipino family with incontinentia pigmenti.
Guevara BE; Hsu CK; Liu L; Feast A; Alabado KL; Lacuesta MP; Lee JY; McGrath JA
Australas J Dermatol; 2016 May; 57(2):150-3. PubMed ID: 26437686
[TBL] [Abstract][Full Text] [Related]
17. [Incontinentia pigmenti (Bloch-Sulzberger syndrome)].
Mühlenstädt E; Eigelshoven S; Hoff NP; Reifenberger J; Homey B; Bruch-Gerharz D
Hautarzt; 2010 Oct; 61(10):831-3. PubMed ID: 20865235
[TBL] [Abstract][Full Text] [Related]
18. Incontinentia pigmenti with ultrastructurally disordered leucocytes.
Minić S; Trpinac D; Obradović M; Novotny GE; Gabriel HD; Kuhn M
J Clin Pathol; 2010 Jul; 63(7):657-9. PubMed ID: 20591917
[TBL] [Abstract][Full Text] [Related]
19. A successful treatment of tadalafil in incontinentia pigmenti with pulmonary hypertension.
Mizuno M; Aso K; Tsuzuki Y; Kitazawa T; Migita O; Hokuto I; Yamamoto H
Eur J Med Genet; 2020 Mar; 63(3):103764. PubMed ID: 31518693
[TBL] [Abstract][Full Text] [Related]
20. [Incontinentia pigmenti. Four patients with different clinical manifestations].
Llano-Rivas I; Soler-Sánchez T; Málaga-Diéguez I; Fernández-Toral J
An Pediatr (Barc); 2012 Mar; 76(3):156-60. PubMed ID: 22036144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
